DAWN KNUTSON: Open Payments
NPI 1700544285 · BLANDINSVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 16 payments from 6 companies in 2025. Trend: 2023 $82 · 2024 $249 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $166 |
| AstraZeneca Pharmaceuticals LP | 5 | $104 |
| Gilead Sciences, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
Products named: Ozempic, AIRSUPRA, MOUNJARO, CAPLYTA, ZEPBOUND, UBRELVY.
Industry payments across IL — which companies pay providers there.
